BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23834686)

  • 1. NaV1.5 and interacting proteins in human arrhythmogenic cardiomyopathy.
    Gillet L; Shy D; Abriel H
    Future Cardiol; 2013 Jul; 9(4):467-70. PubMed ID: 23834686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathy.
    Noorman M; Hakim S; Kessler E; Groeneweg JA; Cox MG; Asimaki A; van Rijen HV; van Stuijvenberg L; Chkourko H; van der Heyden MA; Vos MA; de Jonge N; van der Smagt JJ; Dooijes D; Vink A; de Weger RA; Varro A; de Bakker JM; Saffitz JE; Hund TJ; Mohler PJ; Delmar M; Hauer RN; van Veen TA
    Heart Rhythm; 2013 Mar; 10(3):412-9. PubMed ID: 23178689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced sodium channels in human ARVC.
    Shaw RM
    Heart Rhythm; 2013 Mar; 10(3):420-1. PubMed ID: 23266405
    [No Abstract]   [Full Text] [Related]  

  • 4. Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease).
    Kaplan SR; Gard JJ; Protonotarios N; Tsatsopoulou A; Spiliopoulou C; Anastasakis A; Squarcioni CP; McKenna WJ; Thiene G; Basso C; Brousse N; Fontaine G; Saffitz JE
    Heart Rhythm; 2004 May; 1(1):3-11. PubMed ID: 15851108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular composition of the intercalated disc in a spontaneous canine animal model of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Oxford EM; Everitt M; Coombs W; Fox PR; Kraus M; Gelzer AR; Saffitz J; Taffet SM; Moïse NS; Delmar M
    Heart Rhythm; 2007 Sep; 4(9):1196-205. PubMed ID: 17765621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing the Molecular Pathology of Arrhythmogenic Cardiomyopathy in Patient Buccal Mucosa Cells.
    Asimaki A; Protonotarios A; James CA; Chelko SP; Tichnell C; Murray B; Tsatsopoulou A; Anastasakis A; te Riele A; Kléber AG; Judge DP; Calkins H; Saffitz JE
    Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e003688. PubMed ID: 26850880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
    Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
    Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular changes in the heart of a severe case of arrhythmogenic right ventricular cardiomyopathy caused by a desmoglein-2 null allele.
    Gehmlich K; Syrris P; Reimann M; Asimaki A; Ehler E; Evans A; Quarta G; Pantazis A; Saffitz JE; McKenna WJ
    Cardiovasc Pathol; 2012; 21(4):275-82. PubMed ID: 22036071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal connexin43 in arrhythmogenic right ventricular cardiomyopathy caused by plakophilin-2 mutations.
    Fidler LM; Wilson GJ; Liu F; Cui X; Scherer SW; Taylor GP; Hamilton RM
    J Cell Mol Med; 2009 Oct; 13(10):4219-28. PubMed ID: 18662195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis.
    Te Riele AS; Agullo-Pascual E; James CA; Leo-Macias A; Cerrone M; Zhang M; Lin X; Lin B; Sobreira NL; Amat-Alarcon N; Marsman RF; Murray B; Tichnell C; van der Heijden JF; Dooijes D; van Veen TA; Tandri H; Fowler SJ; Hauer RN; Tomaselli G; van den Berg MP; Taylor MR; Brun F; Sinagra G; Wilde AA; Mestroni L; Bezzina CR; Calkins H; Peter van Tintelen J; Bu L; Delmar M; Judge DP
    Cardiovasc Res; 2017 Jan; 113(1):102-111. PubMed ID: 28069705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of desmoplakin decreases connexin43/Nav1.5 expression and sodium current in HL‑1 cardiomyocytes.
    Zhang Q; Deng C; Rao F; Modi RM; Zhu J; Liu X; Mai L; Tan H; Yu X; Lin Q; Xiao D; Kuang S; Wu S
    Mol Med Rep; 2013 Sep; 8(3):780-6. PubMed ID: 23877755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remodeling of cell-cell junctions in arrhythmogenic cardiomyopathy.
    Asimaki A; Saffitz JE
    Cell Commun Adhes; 2014 Feb; 21(1):13-23. PubMed ID: 24460198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normalization of Naxos plakoglobin levels restores cardiac function in mice.
    Zhang Z; Stroud MJ; Zhang J; Fang X; Ouyang K; Kimura K; Mu Y; Dalton ND; Gu Y; Bradford WH; Peterson KL; Cheng H; Zhou X; Chen J
    J Clin Invest; 2015 Apr; 125(4):1708-12. PubMed ID: 25705887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac tissue-restricted deletion of plakoglobin results in progressive cardiomyopathy and activation of {beta}-catenin signaling.
    Li J; Swope D; Raess N; Cheng L; Muller EJ; Radice GL
    Mol Cell Biol; 2011 Mar; 31(6):1134-44. PubMed ID: 21245375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy.
    Asimaki A; Syrris P; Wichter T; Matthias P; Saffitz JE; McKenna WJ
    Am J Hum Genet; 2007 Nov; 81(5):964-73. PubMed ID: 17924338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Connexin43 remodeling caused by inhibition of plakophilin-2 expression in cardiac cells.
    Oxford EM; Musa H; Maass K; Coombs W; Taffet SM; Delmar M
    Circ Res; 2007 Sep; 101(7):703-11. PubMed ID: 17673670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
    Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
    Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of cadherin-binding proteins β-catenin and plakoglobin in the heart leads to gap junction remodeling and arrhythmogenesis.
    Swope D; Cheng L; Gao E; Li J; Radice GL
    Mol Cell Biol; 2012 Mar; 32(6):1056-67. PubMed ID: 22252313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arytmogenic ventricular cardiomyopathy].
    Tomášek P; Dohnalová P; Kubíková T; Králíčková M; Beran M; Tonar Z
    Soud Lek; 2015; 60(4):51-6. PubMed ID: 26585306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remodelling of myocardial intercalated disc protein connexin 43 causes increased susceptibility to malignant arrhythmias in ARVC/D patients.
    Chen X; Chen L; Chen Z; Chen X; Song J
    Forensic Sci Int; 2017 Jun; 275():14-22. PubMed ID: 28288337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.